Načítá se...
Impact of Selective CD28 Blockade on Virus-Specific Immunity to a Murine EBV Homolog
CTLA-4Ig (belatacept) blocks the CD80/CD86 ligands for both CD28 and CTLA-4; thus, in addition to the intended effect of blocking CD28-mediated costimulation, belatacept also has the unintended effect of blocking CTLA-4-mediated coinhibition. Recently, anti-CD28 domain antibodies (dAb) that selectiv...
Uloženo v:
| Vydáno v: | Am J Transplant |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6658342/ https://ncbi.nlm.nih.gov/pubmed/30801917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.15321 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|